MEDIOS AG (ILM1.DE) Fundamental Analysis & Valuation

FRA:ILM1 • DE000A1MMCC8

15.64 EUR
+0.36 (+2.36%)
Last: Mar 10, 2026, 07:00 PM

This ILM1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

ILM1 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for ILM1 as it has an excellent financial health rating, but there are worries on the profitability. ILM1 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. ILM1.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ILM1 was profitable.
  • ILM1 had a positive operating cash flow in the past year.
  • Each year in the past 5 years ILM1 has been profitable.
  • Of the past 5 years ILM1 4 years had a positive operating cash flow.
ILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

  • The Return On Assets of ILM1 (2.34%) is comparable to the rest of the industry.
  • ILM1 has a Return On Equity of 4.25%. This is in the lower half of the industry: ILM1 underperforms 63.64% of its industry peers.
  • ILM1's Return On Invested Capital of 3.73% is on the low side compared to the rest of the industry. ILM1 is outperformed by 63.64% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ILM1 is below the industry average of 6.06%.
  • The 3 year average ROIC (3.26%) for ILM1 is below the current ROIC(3.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROIC 3.73%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ILM1.DE Yearly ROA, ROE, ROICILM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • ILM1 has a Profit Margin (1.09%) which is comparable to the rest of the industry.
  • ILM1's Profit Margin has declined in the last couple of years.
  • ILM1's Operating Margin of 2.21% is on the low side compared to the rest of the industry. ILM1 is outperformed by 78.79% of its industry peers.
  • In the last couple of years the Operating Margin of ILM1 has declined.
  • The Gross Margin of ILM1 (9.66%) is worse than 66.67% of its industry peers.
  • ILM1's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
ILM1.DE Yearly Profit, Operating, Gross MarginsILM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

7

2. ILM1.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ILM1 is destroying value.
  • ILM1 has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ILM1 has more shares outstanding
  • The debt/assets ratio for ILM1 is higher compared to a year ago.
ILM1.DE Yearly Shares OutstandingILM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ILM1.DE Yearly Total Debt VS Total AssetsILM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • ILM1 has an Altman-Z score of 3.20. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
  • ILM1 has a Altman-Z score of 3.20. This is amongst the best in the industry. ILM1 outperforms 87.88% of its industry peers.
  • ILM1 has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as ILM1 would need 2.17 years to pay back of all of its debts.
  • ILM1 has a Debt to FCF ratio of 2.17. This is amongst the best in the industry. ILM1 outperforms 96.97% of its industry peers.
  • ILM1 has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.32, ILM1 belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Altman-Z 3.2
ROIC/WACC0.55
WACC6.78%
ILM1.DE Yearly LT Debt VS Equity VS FCFILM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • ILM1 has a Current Ratio of 1.74. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ILM1 (1.74) is better than 81.82% of its industry peers.
  • A Quick Ratio of 1.31 indicates that ILM1 should not have too much problems paying its short term obligations.
  • The Quick ratio of ILM1 (1.31) is better than 78.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.31
ILM1.DE Yearly Current Assets VS Current LiabilitesILM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. ILM1.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.63% over the past year.
  • ILM1 shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.00% yearly.
  • The Revenue has grown by 9.27% in the past year. This is quite good.
  • ILM1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.51% yearly.
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%

3.2 Future

  • Based on estimates for the next years, ILM1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.17% on average per year.
  • Based on estimates for the next years, ILM1 will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue Next Year8.39%
Revenue Next 2Y6.17%
Revenue Next 3Y5.58%
Revenue Next 5Y3.16%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ILM1.DE Yearly Revenue VS EstimatesILM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
ILM1.DE Yearly EPS VS EstimatesILM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. ILM1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.98 indicates a rather expensive valuation of ILM1.
  • ILM1's Price/Earnings ratio is in line with the industry average.
  • ILM1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.25.
  • A Price/Forward Earnings ratio of 11.18 indicates a reasonable valuation of ILM1.
  • ILM1's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ILM1 is cheaper than 78.79% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.39. ILM1 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.98
Fwd PE 11.18
ILM1.DE Price Earnings VS Forward Price EarningsILM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ILM1's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ILM1 is cheaper than 87.88% of the companies in the same industry.
  • 84.85% of the companies in the same industry are more expensive than ILM1, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.37
EV/EBITDA 5.99
ILM1.DE Per share dataILM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILM1 does not grow enough to justify the current Price/Earnings ratio.
  • ILM1's earnings are expected to grow with 19.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.39
PEG (5Y)N/A
EPS Next 2Y17.64%
EPS Next 3Y19.17%

0

5. ILM1.DE Dividend Analysis

5.1 Amount

  • ILM1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ILM1.DE Fundamentals: All Metrics, Ratios and Statistics

MEDIOS AG

FRA:ILM1 (3/10/2026, 7:00:00 PM)

15.64

+0.36 (+2.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11
Earnings (Next)03-26
Inst Owners38.15%
Inst Owner ChangeN/A
Ins Owners19.7%
Ins Owner ChangeN/A
Market Cap398.98M
Revenue(TTM)2.01B
Net Income(TTM)22.03M
Analysts87.27
Price Target24.48 (56.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 17.98
Fwd PE 11.18
P/S 0.2
P/FCF 4.37
P/OCF 4.04
P/B 0.77
P/tB 14.52
EV/EBITDA 5.99
EPS(TTM)0.87
EY5.56%
EPS(NY)1.4
Fwd EY8.95%
FCF(TTM)3.58
FCFY22.88%
OCF(TTM)3.87
OCFY24.75%
SpS78.89
BVpS20.31
TBVpS1.08
PEG (NY)3.39
PEG (5Y)N/A
Graham Number19.94
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 4.25%
ROCE 6.15%
ROIC 3.73%
ROICexc 4.29%
ROICexgc 19.24%
OM 2.21%
PM (TTM) 1.09%
GM 9.66%
FCFM 4.54%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexgc growth 3Y-0.85%
ROICexgc growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score7
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.17
Debt/EBITDA 2.04
Cap/Depr 19.67%
Cap/Sales 0.37%
Interest Coverage 3.48
Cash Conversion 119.67%
Profit Quality 414.43%
Current Ratio 1.74
Quick Ratio 1.31
Altman-Z 3.2
F-Score7
WACC6.78%
ROIC/WACC0.55
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.63%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%80.36%
EPS Next Y5.3%
EPS Next 2Y17.64%
EPS Next 3Y19.17%
EPS Next 5YN/A
Revenue 1Y (TTM)9.27%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%9.13%
Revenue Next Year8.39%
Revenue Next 2Y6.17%
Revenue Next 3Y5.58%
Revenue Next 5Y3.16%
EBIT growth 1Y59.29%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year99.49%
EBIT Next 3Y34.03%
EBIT Next 5Y29.68%
FCF growth 1Y229.48%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y228.59%
OCF growth 3Y6.19%
OCF growth 5YN/A

MEDIOS AG / ILM1.DE FAQ

What is the fundamental rating for ILM1 stock?

ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE.


What is the valuation status of MEDIOS AG (ILM1.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDIOS AG (ILM1.DE). This can be considered as Fairly Valued.


How profitable is MEDIOS AG (ILM1.DE) stock?

MEDIOS AG (ILM1.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for ILM1 stock?

The Earnings per Share (EPS) of MEDIOS AG (ILM1.DE) is expected to grow by 5.3% in the next year.


How sustainable is the dividend of MEDIOS AG (ILM1.DE) stock?

The dividend rating of MEDIOS AG (ILM1.DE) is 0 / 10 and the dividend payout ratio is 0%.